66 related articles for article (PubMed ID: 17703250)
1. Hospitalization-based major comorbidity of inflammatory bowel disease in Canada.
Bernstein CN; Nabalamba A
Can J Gastroenterol; 2007 Aug; 21(8):507-11. PubMed ID: 17703250
[TBL] [Abstract][Full Text] [Related]
2. Comorbidity prevalence among cancer patients: a population-based cohort study of four cancers.
Fowler H; Belot A; Ellis L; Maringe C; Luque-Fernandez MA; Njagi EN; Navani N; Sarfati D; Rachet B
BMC Cancer; 2020 Jan; 20(1):2. PubMed ID: 31987032
[TBL] [Abstract][Full Text] [Related]
3. Prevalence and outcome of acute pulmonary embolism in hospitalized patients with a history of inflammatory bowel disease.
Iourinets J; Sawalski C; Desai P; Sutherland D; Shah P; Bruno E; Arora P; Malik M; Patel A; Akhtar T; Fareed J; Brailovsky Y; Naik A; Darki A
Thromb Res; 2024 Jul; 239():109035. PubMed ID: 38805780
[No Abstract] [Full Text] [Related]
4. Effectiveness and safety of prophylactic anticoagulation among hospitalized patients with inflammatory bowel disease.
Dawwas GK; Cuker A; Schaubel DE; Lewis JD
Blood Adv; 2024 Mar; 8(5):1272-1280. PubMed ID: 38163322
[TBL] [Abstract][Full Text] [Related]
5. Thromboembolic Events in Patients with Inflammatory Bowel Disease: A Comprehensive Overview.
Gala D; Newsome T; Roberson N; Lee SM; Thekkanal M; Shah M; Kumar V; Bandaru P; Gayam V
Diseases; 2022 Sep; 10(4):. PubMed ID: 36278572
[TBL] [Abstract][Full Text] [Related]
6. The risk of venous thromboembolic events in patients with inflammatory bowel disease: a systematic review and meta-analysis.
Arvanitakis KD; Arvanitaki AD; Karkos CD; Zintzaras EΑ; Germanidis GS
Ann Gastroenterol; 2021; 34(5):680-690. PubMed ID: 34475739
[TBL] [Abstract][Full Text] [Related]
7. Validation of an electronic algorithm for Hodgkin and non-Hodgkin lymphoma in ICD-10-CM.
Epstein MM; Dutcher SK; Maro JC; Saphirak C; DeLuccia S; Ramanathan M; Dhawale T; Harchandani S; Delude C; Hou L; Gertz A; DiNunzio N; McMahill-Walraven CN; Selvan MS; Vigeant J; Cole DV; Leishear K; Gurwitz JH; Andrade S; Cocoros NM
Pharmacoepidemiol Drug Saf; 2021 Jul; 30(7):910-917. PubMed ID: 33899311
[TBL] [Abstract][Full Text] [Related]
8. Utilisation and outcomes of allogeneic hematopoietic cell transplantation in Ontario, Canada, and New York State, USA: a population-based retrospective cohort study.
Hershenfeld SA; Matelski J; Ling V; Paterson M; Cheung M; Cram P
BMJ Open; 2020 Oct; 10(10):e039293. PubMed ID: 33130568
[TBL] [Abstract][Full Text] [Related]
9. Absence of Day 3 Steroid Response Predicts Colitis-Related Complications and Colectomy in Hospitalized Ulcerative Colitis Patients.
Leung K; Rhee G; Parlow S; Bollu A; Sabri E; McCurdy JD; Murthy SK
J Can Assoc Gastroenterol; 2020 Aug; 3(4):169-176. PubMed ID: 32671326
[TBL] [Abstract][Full Text] [Related]
10. Hepatic and intestinal biotransformation gene expression and drug disposition in a dextran sulfate sodium-induced colitis mouse model.
Fan X; Ding X; Zhang QY
Acta Pharm Sin B; 2020 Jan; 10(1):123-135. PubMed ID: 31993311
[TBL] [Abstract][Full Text] [Related]
11. Increased Transfusion Requirements with Pharmacologic Thromboembolism Prophylaxis During Inflammatory Bowel Disease Exacerbation.
Sultan K; Shah D; Bhorania K; Zhou E; Khan S; Kohn N; Qiu M; Spyropoulos A
Dig Dis Sci; 2019 Nov; 64(11):3256-3262. PubMed ID: 31065899
[TBL] [Abstract][Full Text] [Related]
12. Ulcerative colitis flare with splenic ven thrombosis.
Bozkurt HS; Kara B; Citil S
Int J Clin Exp Med; 2015; 8(3):4712-4. PubMed ID: 26064409
[TBL] [Abstract][Full Text] [Related]
13. Inflammatory bowel disease and thromboembolism.
Zezos P; Kouklakis G; Saibil F
World J Gastroenterol; 2014 Oct; 20(38):13863-78. PubMed ID: 25320522
[TBL] [Abstract][Full Text] [Related]
14. Pulmonary manifestations of inflammatory bowel disease.
Ji XQ; Wang LX; Lu DG
World J Gastroenterol; 2014 Oct; 20(37):13501-11. PubMed ID: 25309080
[TBL] [Abstract][Full Text] [Related]
15. Defining quality indicators for best-practice management of inflammatory bowel disease in Canada.
Nguyen GC; Devlin SM; Afif W; Bressler B; Gruchy SE; Kaplan GG; Oliveira L; Plamondon S; Seow CH; Williams C; Wong K; Yan BM; Jones J
Can J Gastroenterol Hepatol; 2014 May; 28(5):275-85. PubMed ID: 24839622
[TBL] [Abstract][Full Text] [Related]
16. Venous thrombosis and prothrombotic factors in inflammatory bowel disease.
Magro F; Soares JB; Fernandes D
World J Gastroenterol; 2014 May; 20(17):4857-72. PubMed ID: 24803797
[TBL] [Abstract][Full Text] [Related]
17. Physicians' perceptions of risks and practices in venous thromboembolism prophylaxis in inflammatory bowel disease.
Sam JJ; Bernstein CN; Razik R; Thanabalan R; Nguyen GC
Dig Dis Sci; 2013 Jan; 58(1):46-52. PubMed ID: 23053902
[TBL] [Abstract][Full Text] [Related]
18. Venous thromboembolism after surgery for inflammatory bowel disease: are there modifiable risk factors? Data from ACS NSQIP.
Wallaert JB; De Martino RR; Marsicovetere PS; Goodney PP; Finlayson SR; Murray JJ; Holubar SD
Dis Colon Rectum; 2012 Nov; 55(11):1138-44. PubMed ID: 23044674
[TBL] [Abstract][Full Text] [Related]
19. Autoimmune diseases and venous thromboembolism: a review of the literature.
Zöller B; Li X; Sundquist J; Sundquist K
Am J Cardiovasc Dis; 2012; 2(3):171-83. PubMed ID: 22937487
[TBL] [Abstract][Full Text] [Related]
20. Comorbidity in inflammatory bowel disease.
Román AL; Muñoz F
World J Gastroenterol; 2011 Jun; 17(22):2723-33. PubMed ID: 21734780
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
